StockDuty ← Dashboard Sep 23, 2026 11:44 AM ET
SignalCorporate

Autologous Hematopoietic Stem Cell Gene Therapy Market Global Report 2026: A $13.44 Billion Market by 2030 as Novartis, Vertex, CRISPR Therapeutics and Orchard Therapeutics Accelerate the Gene-Editing

$13.44 billion market by 2030 with Novartis, Vertex, CRISPR and Orchard accelerating gene-editing race.

What changed
$13.44 billion market by 2030 with Novartis, Vertex, CRISPR and Orchard accelerating gene-editing race.
Why it matters
$13.44 billion market by 2030 with Novartis, Vertex, CRISPR and Orchard accelerating gene-editing race. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →